INTRODUCTION
Elizabethkingia (E.) meningoseptica, formerly known as Chryseobacterium meningosepticum, is an oxidasepositive, catalase-positive, non-glucose fermenting, and gram-negative bacillus that belongs to the genus Chryseobacterium. Eponymously named after Elizabeth King who first described this bacterium in 1959, this ubiquitous organism has been traditionally considered as a contaminant of blood cultures. 1 Reports published over the past two decades have shown that this bacterium can cause infections in both immunocompromised and immunocompetent patients. 2 E. meningoseptica has been recognized as a frequent colonizer of bile, especially following endoscopic biliary tract procedures. Although it rarely causes biliary tract infection, cholangitis due to E. meningoseptica is generally associated with a favourable prognosis. 3 Here, we report the case of an elderly lady who developed cholangitis due to E. meningoseptica following biliary stent placement and died subsequently because of septic shock.
CASE REPORT
A 70-year female with past history of hypertension and ischemic heart disease underwent work-up for obstructive jaundice at our hospital. She was diagnosed to have unresectable, peri-ampullary carcinoma and underwent palliative biliary stenting. Shortly after being discharged from the hospital, she presented again to the emergency department with fever, abdominal pain, and shortness of breath. On physical examination, she was febrile, tachycardiac, tachypneic and icteric. She was maintaining 92% oxygen saturation on room air. Chest auscultation was notable for harsh vesicular breathing with bilateral fine crackles. A plain chest radiograph was obtained, which revealed bilateral interstitial infiltrates. Ultrasonography of the abdomen was also performed, which revealed minimal dilatation of extra-and intra-hepatic biliary channels. Blood, urine, and sputum cultures were sent and the patient was started empirically on clarithromycin (500 mg 2×/d), metronidazole (500 mg 3×/d) and ceftriaxone (2000 mg 1×/d). However, the patient's condition progressively worsened and she began to develop worsening respiratory failure. Arterial blood gas obtained on supplemental oxygen revealed partial pressure of oxygen of 51 mm Hg (reference: 70-100 mm Hg), partial pressure of carbon dioxide of 28 mm Hg (reference: 36-40 mm Hg), and bicarbonate concentration of 18 mmol/L (reference: 22-28 mmol/L). Due to worsening tachypnea and respiratory failure, endotracheal intubation was performed and she was shifted to the intensive care unit. Subsequently, a central venous catheter was inserted through the right femoral vein.
After about 48 hours, the patient continued to have spiking fever and was started on imipenem/cilastatin (500 mg 4×/d) and vancomycin (1000 mg 2×/d). Preliminary reports of blood cultures revealed growth of E. meningoseptica, which was disregarded as a contaminant initially. However, the patient's condition did not improve and final reports of tracheal, blood, and urine cultures showed growth of >105 CFU/mL of E. meningoseptica. Urine culture also grew vancomycinresistant enterococcus fecalis. E. meningoseptica was sensitive to piperacillin-tazobactam and vancomycin, while enterococcus fecalis was sensitive to linezolid.
In consultation with infectious disease specialists, antibiotic therapy with piperacillin-tazobactam (4450 mg 3×/d), vancomycin (1000 mg 2×/d) and linezolid (600 mg 2×/d) was instituted (on the fourth day of admission). However, the patient's condition continued to deteriorate and she developed multi-organ dysfunction. Her arterial serum lactate rose to 4.5 mmol/L (reference: 0.6-2.2 mmol/L) and she began to develop hypotension (mean arterial pressure of less than 65 mm Hg). An arterial catheter was inserted for invasive blood pressure monitoring and norepinephrine infusion (3 mcg/minute) was started. Despite vasopressor support, patient went into cardiac arrest and could not be revived.
DISCUSSION
This case emphasizes the importance of considering E. meningoseptica as a potential pathogen of the biliary tract infection. This is in contrast with previously published evidence which suggested that cholangitis with E. meningoseptica following endoscopic procedures is associated with a good prognosis. Most strains of E. meningoseptica are resistant to carbapenems (conferred by the metallo--lactamase, BlaB) and this is the only bacterium known to have two chromosomallyencoded metallo--lactamase genes. 4 This organism is peculiar in that it is often sensitive to piperacillintazobactam, despite being resistant to carbapenem; and vancomycin has good activity against this organism, even though it is a gram-negative bacillus. 5 Due to these unique antibiotic susceptibilities, clinicians must keep E. meningoseptica in mind as a potential pathogen in patients who develop biliary sepsis following endoscopic procedures. A delay in recognizing this pathogen or disregarding it as a contaminant could have disastrous consequences for patients, as happened in the present case.
